The temporal relationship between medication initiation and symptom onset provides important diagnostic information, but does not confirm causation
Whether retatrutide carries the same risk is not yet established
its a metabolic liability, says Sangeeta Kashyap, MD, assistant chief of clinical affairs at New York-Presbyterian/Weill Cornell Medical Center
Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Sillje HH: Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A
There are no known interactions between the two
All research must be conducted by qualified scientists in controlled laboratory settings following appropriate safety protocols and regulatory guidelines